Sally Cheuk Ying Wong

Dr. Sally Cheuk Ying Wong

Department of Pathology, Hong Kong Children's Hospital, Hong Kong, China
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Franklin Wang Ngai CHOWFranklin Wang Ngai CHOW
Franklin Wang Ngai CHOW
TCTony Tat-Yin Chan
Tony Tat-Yin Chan
ATAnthony Raymond Tam
Anthony Raymond Tam
SZSuhui Zhao
Suhui Zhao
WYWeiming Yao
Weiming Yao
Susanna K. P. LauSusanna K. P. Lau
Susanna K. P. Lau
To control the COVID-19 pandemic and prevent its resurgence in areas preparing for a return of economic activities, a method for a rapid, simple, and inexpensive point-of-care diagnosis and mass screening is urgently needed. We developed and evaluated a one-step colorimetric reverse-transcriptional loop-mediated isothermal amplification assay (COVID-19-LAMP) for detection of SARS-CoV-2, using SARS-CoV-2 isolate and respiratory samples from patients with COVID-19 (n = 223) and other respiratory virus infections (n = 143). The assay involves simple equipment and techniques and low cost, without the need for expensive qPCR machines, and the result, indicated by color change, is easily interpreted by naked eyes. COVID-19-LAMP can detect SARS-CoV-2 RNA with detection limit of 42 copies/reaction. Of 223 respiratory samples positive for SARS-CoV-2 by qRT-PCR, 212 and 219 were positive by COVID-19-LAMP at 60 and 90 min (sensitivities of 95.07% and 98.21%) respectively, with the highest sensitivities among nasopharyngeal swabs (96.88% and 98.96%), compared to sputum/deep throat saliva samples (94.03% and 97.02%), and throat swab samples (93.33% and 98.33%). None of the 143 samples with other respiratory viruses were positive by COVID-19-LAMP, showing 100% specificity. Samples with higher viral load showed shorter detection time, some as early as 30 min. This inexpensive, highly sensitive and specific COVID-19-LAMP assay can be useful for rapid deployment as mobile diagnostic units to resource-limiting areas for point-of-care diagnosis, and for unlimited high-throughput mass screening at borders to reduce cross-regional transmission.

Verified
Journal Article
Open access
PDF file
CYCyril C. Y. Yip
Cyril C. Y. Yip
CHChi-Chun Ho
Chi-Chun Ho
Jasper Fuk Woo ChanJasper Fuk Woo Chan
Jasper Fuk Woo Chan
KTKelvin Kai-Wang To
Kelvin Kai-Wang To
HCHelen Shuk-Ying Chan
Helen Shuk-Ying Chan
KYKwok-Yung Yuen
Kwok-Yung Yuen
The pandemic novel coronavirus infection, Coronavirus Disease 2019 (COVID-19), has affected at least 190 countries or territories, with 465,915 confirmed cases and 21,031 deaths. In a containment-based strategy, rapid, sensitive and specific testing is important in epidemiological control and clinical management. Using 96 SARS-CoV-2 and 104 non-SARS-CoV-2 coronavirus genomes and our in-house program, GolayMetaMiner, four specific regions longer than 50 nucleotides in the SARS-CoV-2 genome were identified. Primers were designed to target the longest and previously untargeted nsp2 region and optimized as a probe-free real-time reverse transcription-polymerase chain reaction (RT-PCR) assay. The new COVID-19-nsp2 assay had a limit of detection (LOD) of 1.8 TCID50/mL and did not amplify other human-pathogenic coronaviruses and respiratory viruses. Assay reproducibility in terms of cycle threshold (Cp) values was satisfactory, with the total imprecision (% CV) values well below 5%. Evaluation of the new assay using 59 clinical specimens from 14 confirmed cases showed 100% concordance with our previously developed COVID-19-RdRp/Hel reference assay. A rapid, sensitive, SARS-CoV-2-specific real-time RT-PCR assay, COVID-19-nsp2, was developed.

Verified
Journal Article
Open access
PDF file
Susanna K. P. LauSusanna K. P. Lau
Susanna K. P. Lau
KLKim-Chung Lee
Kim-Chung Lee
GLGeorge Lo
George Lo
VDVanessa S. Y. Ding
Vanessa S. Y. Ding
Franklin Wang Ngai CHOWFranklin Wang Ngai CHOW
Franklin Wang Ngai CHOW
Patrick WooPatrick Woo
Patrick Woo
To identify potential biomarkers for improving diagnosis of melioidosis, we compared plasma metabolome profiles of melioidosis patients compared to patients with other bacteremia and controls without active infection, using ultra-high-performance liquid chromatography-electrospray ionization-quadruple time-of-flight mass spectrometry. Principal component analysis (PCA) showed that the metabolomic profiles of melioidosis patients are distinguishable from bacteremia patients and controls. Using multivariate and univariate analysis, 12 significant metabolites from four lipid classes, acylcarnitine (n = 6), lysophosphatidylethanolamine (LysoPE) (n = 3), sphingomyelins (SM) (n = 2) and phosphatidylcholine (PC) (n = 1), with significantly higher levels in melioidosis patients than bacteremia patients and controls, were identified. Ten of the 12 metabolites showed area-under-receiver operating characteristic curve (AUC) >0.80 when compared both between melioidosis and bacteremia patients, and between melioidosis patients and controls. SM(d18:2/16:0) possessed the largest AUC when compared, both between melioidosis and bacteremia patients (AUC 0.998, sensitivity 100% and specificity 91.7%), and between melioidosis patients and controls (AUC 1.000, sensitivity 96.7% and specificity 100%). Our results indicate that metabolome profiling might serve as a promising approach for diagnosis of melioidosis using patient plasma, with SM(d18:2/16:0) representing a potential biomarker. Since the 12 metabolites were related to various pathways for energy and lipid metabolism, further studies may reveal their possible role in the pathogenesis and host response in melioidosis.

12 November 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
WFWing-Yu Fung
Wing-Yu Fung
RCRyan Yiu-Fai Cheng
Ryan Yiu-Fai Cheng
AYAnthony Pak-Yuen Yau
Anthony Pak-Yuen Yau
SLSuet-Yi Lee
Suet-Yi Lee
NCNga-Han Chan
Nga-Han Chan
DLDavid Christopher Lung
David Christopher Lung
Objective: To analyze the correlation between scale of Candida auris clustering and extent of environmental contamination, exploring its implications for improving infection control measures in healthcare settings. Design: Retrospective observational study. Setting: An acute hospital and a convalescent hospital in Hong Kong. Patients: Laboratory confirmed C. auris carriers diagnosed in two hospitals between March and October 2023. Methods: C. auris screening was conducted on patients with defined risk factors and through regular surveillance. Environmental samples were collected from high-touch surfaces and air grilles in corresponding wards. Results: One-hundred-seventy new C. auris patients were identified, including 65 from nine outbreaks and 105 sporadic cases. Environmental screening from eight outbreaks and 46 sporadic isolated cases was analyzed. The environmental contamination rate was significantly higher in the outbreak group (15.1% vs 2.6%, P < 0.05). Longer outbreak duration (34 vs 7 days, P < 0.05) and a higher median number of affected patients per outbreak (9 vs 5, P = 0.05) were associated with higher contamination rates. Notably, air grille samples had a significantly higher contamination rate than high-touch surfaces in both the outbreak (31.6% vs 10.2%, P < 0.05) and sporadic groups (4.6% vs 1.5%, P < 0.05). Conclusion: Prolonged and sizeable C. auris clusterings were linked with more extensive environmental contamination, particularly in air grilles, which are often overlooked during decontamination These findings underscore the need for enhanced infection control measures, including thorough environmental decontamination of air ventilation systems, to mitigate transmission risks in healthcare settings.

18 December 2025 in Journal of Infection
Verified
Journal Article
Open access
JSJianwen Situ
Jianwen Situ
TWTsz Chung Wong
Tsz Chung Wong
SWShusheng Wu
Shusheng Wu
ZLZhiyu Li
Zhiyu Li
ESEstie Hon Kiu Shun
Estie Hon Kiu Shun
Siddharth SridharSiddharth Sridhar
Siddharth Sridhar
Rocahepevirus ratti genotype 1 (rHEV), commonly known as rat hepatitis E virus, is a recently identified cause of viral hepatitis. We compared rHEV infections with conventional hepatitis E and measured rHEV seroprevalence in a large diverse human serum cohort. Patients with hepatitis (n=2018) were tested for rHEV RNA in the context of a real-world clinical service in Hong Kong. rHEV IgG seroprevalence in various risk groups were measured using a validated immunoassay. Commensal rats were tested for rHEV RNA and sequences were compared with human-derived strains. From 2017-2025, 22 human rHEV infections were identified. Of these, 14 (63·6%) were immunocompromised compared to 22/78 (28·2%) conventional HEV patients (p<0.01). Hepatitis was milder in rHEV patients, but most immunocompromised rHEV patients progressed to chronic infection. Rat-derived rHEV belonged to two subtypes, one of which infected humans. Of 8294 individuals, 57 (0·7%) tested positive for rHEV IgG compared to 551 (6·6%) for HEV IgG. Increasing age predicted rHEV seropositivity (OR:1·03; 95% CI:1·01-1·05); persons with bloodborne pathogens did not exhibit higher rHEV seroprevalence. rHEV is a sporadic cause of hepatitis in humans with disproportionate clinical significance for immunocompromised hosts. Although clearly linked to rat epizootics, routes of rHEV transmission remain enigmatic.

20 August 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
THTsz-Yung HUI
Tsz-Yung HUI
Hayes LukHayes Luk
Hayes Luk
GCGarnet Choi
Garnet Choi
SCSANDY CHAU
SANDY CHAU
LTLok-Man Tsang
Lok-Man Tsang
DLDavid Christopher Lung
David Christopher Lung
A post-COVID surge of Bordetella pertussis was observed globally. China has reported a high level of macrolide-resistant Bordetella pertussis (MRBP) in recent years; however, the epidemiology of MRBP in Hong Kong remains unknown. We retrieved archived B. pertussis isolates from respiratory samples collected at five regional public hospitals in Hong Kong between 2015 and 2024 and tested their minimum inhibitory concentration (MIC) for macrolides and other non-macrolide antibiotics using the Etest method. All isolates were also subjected to whole genome sequencing for genotypic resistance, Multi-locus Antigen Sequence Typing (MLST) and Multi-locus Variable Number of Tandem Repeat Analysis (MLVA) typing. Twenty-nine isolates of B. pertussis were included in the study. All isolates demonstrating phenotypic macrolide resistance harbored the A2047G mutation while showing low MIC to trimethoprim-sulfamethoxazole, doxycycline, levofloxacin, piperacillin-tazobactam and meropenem. In 2023 and 2024, 100% were MRBP and all belonged to the MT28 clone with the ptxP3 antigenic type. The MRBP isolates in Hong Kong were phylogenetically related to those from mainland China during the same period. There was no obvious correlation between macrolide resistance and clinical presentation, laboratory findings, management and outcome. Phylogenetic analysis suggests that MRBP isolates in Hong Kong and mainland China are closely related.